Literature DB >> 16829988

[HAQ-DI Italian version in systemic sclerosis].

G La Montagna1, G Cuomo, I Chiarolanza, L Ruocco, G Valentini.   

Abstract

OBJECTIVE: To investigate the Italian version of HAQ-DI (Health Assessment Questionnaire Disability Index) in systemic sclerosis (SSc).
METHODS: 121 SSc patients, satisfying ACR criteria for the classification of this disease and consecutively admitted to a tertiary Unit, were invited to participate to the study. The Italian version of HAQ-DI, as validated in rheumatoid arthritis, was administered to each of them. The relationships between this parameter and the following disease aspects: disease subset, wide extent of skin sclerosis, joint contractures, myopathy, active digital ulcers, were investigated.
RESULTS: HAQ-DI resulted to be 0.772+/-0.074 (mean+/-SE) Statistically significant differences in HAQ-DI scores were detected between patients with and respectively without wide extent of skin sclerosis (ie modified Rodnan skin score >14) (1.158+/-0.176 vs 0.652+/-0.076; P<0.001), joints contractures (0.839+/-0.076 vs 0.159+/-0.147; P<0.001), myopathy (1.875+/-0.184 vs 0.656+/-0.071; P<0.001), digital ulcers (1.047+/-0.135 vs 0.680+/-0.109; P=0.006).
CONCLUSIONS: Our data support the validity of the Italian version of HAQ-DI in SSc.

Entities:  

Mesh:

Year:  2006        PMID: 16829988     DOI: 10.4081/reumatismo.2006.112

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  8 in total

1.  The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat's technique and kinesitherapy: a randomized controlled trial.

Authors:  S Maddali-Bongi; G Landi; F Galluccio; A Del Rosso; I Miniati; M L Conforti; R Casale; M Matucci-Cerinic
Journal:  Rheumatol Int       Date:  2010-03-18       Impact factor: 2.631

2.  Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosis.

Authors:  Francesca Ingegnoli; Valentina Galbiati; Patrizia Boracchi; Daniela Comi; Roberta Gualtierotti; Silvana Zeni; Flavio Fantini
Journal:  Clin Rheumatol       Date:  2007-11-27       Impact factor: 2.980

3.  Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).

Authors:  Luiza F Rocha; Roberta G Marangoni; Percival D Sampaio-Barros; Mauricio Levy-Neto; Natalino H Yoshinari; Eloisa Bonfa; Virginia Steen; Sergio C Kowalski
Journal:  Clin Rheumatol       Date:  2013-08-22       Impact factor: 2.980

4.  The Italian version of the Mouth Handicap in Systemic Sclerosis scale (MHISS) is valid, reliable and useful in assessing oral health-related quality of life (OHRQoL) in systemic sclerosis (SSc) patients.

Authors:  S Maddali Bongi; A Del Rosso; I Miniati; F Galluccio; G Landi; G Tai; M Matucci-Cerinic
Journal:  Rheumatol Int       Date:  2011-08-17       Impact factor: 2.631

5.  Efficacy of cilostazol for the treatment of Raynaud's phenomenon in systemic sclerosis patients.

Authors:  Simone Negrini; Francesca Spanò; Elena Penza; Daniela Rollando; Francesco Indiveri; Gilberto Filaci; Francesco Puppo
Journal:  Clin Exp Med       Date:  2015-06-19       Impact factor: 3.984

6.  Outcome of a glucocorticoid discontinuation regimen in patients with inactive systemic sclerosis.

Authors:  Michele Iudici; Serena Vettori; Barbara Russo; Veronica Giacco; Domenico Capocotta; Gabriele Valentini
Journal:  Clin Rheumatol       Date:  2016-05-17       Impact factor: 2.980

7.  Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis.

Authors:  Susanna Maddali Bongi; Angela Del Rosso; Felice Galluccio; Fabrizio Sigismondi; Irene Miniati; M Letizia Conforti; Francesca Nacci; Marco Matucci Cerinic
Journal:  Clin Rheumatol       Date:  2009-06-25       Impact factor: 2.980

8.  Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease.

Authors:  Michele Iudici; Giovanna Cuomo; Serena Vettori; Manuela Avellino; Gabriele Valentini
Journal:  Health Qual Life Outcomes       Date:  2013-02-25       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.